BMY vs PSNL · P/E 17, rev $24.46B vs rev $37.8M
Bristol-Myers Squibb Company (BMY) versus Personalis Inc (PSNL) — a side-by-side from cached financials, not a winner call.
Bristol-Myers Squibb Company (BMY) is a drug manufacturers - general company listed on US. It is led by Chris Boerner.
Personalis Inc (PSNL) is a diagnostics & research company listed on NASDAQ.
Latest reported BMY revenue for 2026-06-30 was $24.46B. Net income was $5.99B. BMY currently screens at market cap $95.36B and trailing P/E 17.5.
Latest reported PSNL revenue for 2026-06-30 was $37.8M. Net income was -$61.7M. PSNL currently screens at market cap $1.02B.
BMY currently screens at market cap $95.36B and trailing P/E 17.5. PSNL currently screens at market cap $1.02B.
Not investment advice. Open the BMY and PSNL stock pages for the full models.
Not investment advice.